elobixibat inhibitor ileal bile acid transporter undergoing development clinical trials treatment chronic constipation irritable bowel syndrome constipation ibsc elobixibat inhibitor ibat alternative name apical sodium bile acid transporter asbt encoded gene asbtibat bile acidsodium symporter responsible reuptake bile acids ileum initial step enterohepatic circulation inhibiting uptake bile acids elobixibat increases bile acid concentration gut accelerates intestinal passage softens stool following several phase ii studies undergoing phase iii drug developed albireo ab licensed ferring pharmaceuticals development albireo partnered ajinomoto pharmaceuticals giving japanbased company rights develop drug market throughout httpsenwikipediaorgwikielobixibat